Beauty Health Company Class A Clas (SKIN)
EBITDA Growth
-64.25%
Quarterly · Period ending:
SKIN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-64.25%period ending
Latest reported-64.25%period ending
SKIN Quarterly EBITDA YoY % (-111.80% → -64.25%)
Year-over-year change
High-resolution chart · PNG
SKIN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -64.2478% | |
| 1,000.738% | |
| 356.5282% | |
| 194.9062% | |
| 151.9522% | |
| -105.2423% | |
| -159.5012% | |
| 92.6682% | |
| -25.5113% | |
| 172.5646% | |
| -62.2542% | |
| -799.9525% | |
| -2.2078% | |
| -133.4444% | |
| 456.9432% | |
| 103.9846% | |
| 111.3659% | |
| 639.233% | |
| -183.3193% | |
| -3,336.9808% | |
| -3,304.3467% | |
| 242.9315% | |
| -111.8027% |